ACROBiosystems is a leading manufacturer of recombinant proteins, critical reagents and kits to support the development of targeted therapeutics. Our catalog includes a comprehensive list of disease-associated biomarkers and drug targets from human and other common species, which are widely used in targets discovery, immunization, screening, preclinical and clinical stages.
So far, ACROBiosystems has been working with more than 3500 pharmaceutical and biotech companies working on biological drug discovery and development globally. Here we analyze our top selling targets in 2018 and 2019 to help you learn the trend from this particular perspective.
The quality of the proteins below have been verified by multiple assays at ACROBiosystems and the protocols can be offered for free.
|Key Product Lines||New Product Launch|
|Fc Receptor Proteins||Full Length CD20 Protein|
|Immune Checkpoint Proteins||CD73 Protein|
|Targets of CAR-T Cell Therapy||Siglec-15 Protein|
|Biotinylated Proteins||Integrin Protein|
|Biosimilar Drug Targets||BCMA Protein|
|FITC and PE-labeled Proteins||FGL1 Protein|
|ELISA Kits for Quantitative Analysis of Therapeutic Antibodies|
|Inhibitor Screening Kits|
|Click here to get more information.|
This web search service is supported by Google Inc.